These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32871223)

  • 1. HPVomics: An integrated resource for the human papillomavirus epitome and therapeutics.
    Gupta AK; Kumar M
    Genomics; 2020 Nov; 112(6):4853-4862. PubMed ID: 32871223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
    Uversky VN; Roman A; Oldfield CJ; Dunker AK
    J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of autophagy by high- and low-risk human papillomaviruses.
    Aranda-Rivera AK; Cruz-Gregorio A; Briones-Herrera A; Pedraza-Chaverri J
    Rev Med Virol; 2021 Mar; 31(2):e2169. PubMed ID: 33590566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of multiepitope therapeutic vaccines against the most prevalent high-risk human papillomaviruses.
    Panahi HA; Bolhassani A; Javadi G; Noormohammadi Z; Agi E
    Immunotherapy; 2020 May; 12(7):459-479. PubMed ID: 32316826
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.
    Garnett TO; Duerksen-Hughes PJ
    Arch Virol; 2006 Dec; 151(12):2321-35. PubMed ID: 16862386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus.
    Gupta AK; Kumar A; Rajput A; Kaur K; Dar SA; Thakur A; Megha K; Kumar M
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
    He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
    Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
    Dong D; Zhu Y; Aili Z; Chen Z; Ding J
    Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.
    Illiano E; Demurtas OC; Massa S; Di Bonito P; Consalvi V; Chiaraluce R; Zanotto C; De Giuli Morghen C; Radaelli A; Venuti A; Franconi R
    J Transl Med; 2016 Jul; 14(1):224. PubMed ID: 27465494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers.
    Dong Z; Hu R; Du Y; Tan L; Li L; Du J; Bai L; Ma Y; Cui H
    Front Immunol; 2020; 11():586796. PubMed ID: 33488587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
    Graham SV
    Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.
    Al Moustafa AE
    Cell Adh Migr; 2015; 9(5):392-3. PubMed ID: 26177717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58.
    Xu WX; Wang J; Tang HP; He YP; Zhu QX; Gupta SK; Gu SH; Huang Q; Ji CN; Liu LF; Li GL; Xu CJ; Xie Y
    Sci Rep; 2016 Oct; 6():34686. PubMed ID: 27708433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
    Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
    Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of HPV
    Namvar A; Panahi HA; Agi E; Bolhassani A
    Biotechnol Lett; 2020 Mar; 42(3):403-418. PubMed ID: 31915962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
    Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
    Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.